FDA Inspection 681204 — Radpharm, Inc.

Radpharm, Inc. — FEI 3008410340

The FDA completed an inspection of Radpharm, Inc. on Aug 31, 2010 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 31, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
741021 CFR 312.53(a)Investigator selection
748221 CFR 312.50General responsibilities of sponsors
753021 CFR 312.62(b)Case history records- inadequate or inadequate
755821 CFR 312.57(c)Record retention requirement
763121 CFR 312.53(c)(4)Financial information - commitment to update

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.